Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) EBT Margin (2016 - 2025)

GeoVax Labs (GOVX) has disclosed EBT Margin for 15 consecutive years, with 630.05% as the latest value for Q2 2025.

  • On a quarterly basis, EBT Margin rose 105417.0% to 630.05% in Q2 2025 year-over-year; TTM through Sep 2025 was 754.69%, a 3239.0% increase, with the full-year FY2024 number at 631.98%, changed N/A from a year prior.
  • EBT Margin was 630.05% for Q2 2025 at GeoVax Labs, down from 327.31% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 208.48% in Q3 2024 to a low of 8331.01% in Q4 2021.
  • A 4-year average of 2480.75% and a median of 1549.78% in 2024 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: crashed -779985bps in 2021, then soared 105417bps in 2025.
  • GeoVax Labs' EBT Margin stood at 8331.01% in 2021, then surged by 64bps to 2977.6% in 2022, then skyrocketed by 68bps to 955.87% in 2024, then soared by 34bps to 630.05% in 2025.
  • Per Business Quant, the three most recent readings for GOVX's EBT Margin are 630.05% (Q2 2025), 327.31% (Q1 2025), and 955.87% (Q4 2024).